View in EDS HTML Full Text PDF Full Text

The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review.

Saved in:
Bibliographic Details
Title: The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review.
Authors: Aqel A; Hamad Medical Corporation, Internal Medicine, Doha, Qatar., Al-Asa'd Y; Hamad Medical Corporation, Internal Medicine, Doha, Qatar., Al-Kindi S; Department of Haematology, Sultan Qaboos University, Muscat, Oman., Altouk J; Department of Internal Medicine, Bahrain Salmania Hospital, Manama, Bahrain., Zayed AA; Qatif Central Hospital, Qatif, Saudi Arabia., Al-Abdulmalek A; Division of Hematology, McGill University, Montréal, QC, Canada., Yassin MA; Department of Haematology, NCCCR, Hamad Medical Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.
Source: Frontiers in medicine [Front Med (Lausanne)] 2025 Sep 16; Vol. 12, pp. 1651895. Date of Electronic Publication: 2025 Sep 16 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41035870
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aqel+A%22">Aqel A</searchLink>; Hamad Medical Corporation, Internal Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Asa'd+Y%22">Al-Asa'd Y</searchLink>; Hamad Medical Corporation, Internal Medicine, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Kindi+S%22">Al-Kindi S</searchLink>; Department of Haematology, Sultan Qaboos University, Muscat, Oman.<br /><searchLink fieldCode="AU" term="%22Altouk+J%22">Altouk J</searchLink>; Department of Internal Medicine, Bahrain Salmania Hospital, Manama, Bahrain.<br /><searchLink fieldCode="AU" term="%22Zayed+AA%22">Zayed AA</searchLink>; Qatif Central Hospital, Qatif, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Al-Abdulmalek+A%22">Al-Abdulmalek A</searchLink>; Division of Hematology, McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Yassin+MA%22">Yassin MA</searchLink>; Department of Haematology, NCCCR, Hamad Medical Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2025 Sep 16; Vol. 12, pp. 1651895. <i>Date of Electronic Publication: </i>2025 Sep 16 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41035870
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2025.1651895
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1651895
    Titles:
      – TitleFull: The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aqel A
      – PersonEntity:
          Name:
            NameFull: Al-Asa'd Y
      – PersonEntity:
          Name:
            NameFull: Al-Kindi S
      – PersonEntity:
          Name:
            NameFull: Altouk J
      – PersonEntity:
          Name:
            NameFull: Zayed AA
      – PersonEntity:
          Name:
            NameFull: Al-Abdulmalek A
      – PersonEntity:
          Name:
            NameFull: Yassin MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 09
              Text: 2025 Sep 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1